Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

June 30, 2017

Conditions
Type 1 Diabetes
Interventions
DRUG

Ustekinumab

Trial Locations (1)

V5Z 1M9

BC Diabetes, Vancouver

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of British Columbia

OTHER